As Russia’s clinical trials sector falls, Ukraine rebuilds
August 24 marks six months since the start of Russia’s war in Ukraine. A United Nations update on August 15…
All articles by Reynald Castañeda
Reynald Castañeda
@pharmarey
Reynald Castañeda is the lead editor of Clinical Trials Arena. Reynald's coverage focuses on outsourcing, partnering, and supply chains. An experienced healthcare journalist, he was previously an associate editor for GlobalData’s Investigative News Team, writing scoops and feature news articles on drug development.
-
-
Foreign direct investment in clinical trials revs up after pandemic hit the breaks
The Covid-19 pandemic caused overall greenfield foreign direct investment (FDI) project numbers to decline by 17.5% in 2020. However, as the world…
-
Back to the future: the evolution of clinical conference topics in the past decade
When the Covid-19 pandemic struck, in person events such as clinical trial conferences came to a standstill, with the sector…
-
Internet of Things: a tsunami of clinical trial data
Internet of Things (IoT) is the catchall term covering devices that collect and exchange data with other devices over the…
-
Where’s the demand in human challenge clinical trials?
In the early months of the pandemic, human challenge clinical trials drew amplified public interest on its potential to accelerate…
-
Beyond biopsy: how noninvasive NASH tests can move the needle
Liver biopsy—a process whereby a small piece of liver tissue is extracted via a needle—is the reigning gold standard to…
-
IRT in clinical trials: what to add to your shopping list
Interactive response technology (IRT) is at the heart of clinical trials: the software system is used to randomise patients and…
-
Overcoming obstacles in trans and nonbinary participation in clinical trials
Diversity in clinical trials is an even bigger topic this year, with the sector looking for ways to increase representation…
-
Should rheumatoid arthritis trials exclude patients based on their Covid-19 vaccine status?
Covid-19 continues to make an impact on clinical trial design, and rheumatoid arthritis (RA) is no exception. While more evidence…
-
Beyond clinical trial design: factors that impact decentralisation
When it comes to integrating decentralised elements into a clinical trial, the patient is the centre of the issue. And…